Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • breezerwave breezerwave Dec 7, 2012 4:04 AM Flag

    Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

    Estimated Study Completion Date: December 2012
    Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)

    Sentiment: Strong Buy

 
EXEL
7.81+0.01(+0.13%)Jun 30 4:00 PMEDT